Position Statements for the Implementation of Oncology Biosimilars from the pan-Canadian Clinical Operations Working Group

This report has been prepared by Cancer Care Ontario and is part of the pan-Canadian Oncology Biosimilars Initiative, funded by the pan-Canadian Pharmaceutical Alliance. https://healthpro-production.s3.ca-central-1.amazonaws.com/Position_Statement_from_the_pan-Canadian_Clinical_Operations_Working_Group__002__-_Oct_11th__2019.pdf